Back to top

Analyst Blog

Allscripts Healthcare Solutions (MDRX - Analyst Report) revealed that it has expanded its partnership with academic medical center and the University Hospital for Albert Einstein College of Medicine, Montefiore Health System for offering its Electronic Health Record (EHR) solutions to the latter’s recently acquired New Rochelle and Mount Vernon hospitals in New York.

Under the new agreement, MDRX will upgrade the two hospitals with its Allscripts Sunrise 6.1 Integrated Electronic Health Record as well as the Sunrise Clinical Analytics, Sunrise Radiology, and Sunrise Laboratory. The company will also implement Allscripts FollowMyHealth patient engagement solution at the two hospitals under the same agreement.

Montefiore Health System operates six hospitals and an extended care facility having a total of 2,059 beds. It also provides primary and specialty care through more than 150 locations across the U.S., including the largest school health program and a home health program.

The good thing about Allscripts Sunrise 6.1 solution is that it enables clinicians meet Meaningful Use Stage 1 and 2 requirements and help managing ICD-10 code sets. On the other hand, Allscripts FollowMyHealth patient engagement solution helps health care providers gain access to an online patient portal and enables exchange of critical patient data that can empower patients to proactively manage their health.

Allscripts’ Sunrise Suite is a well known product among healthcare providers in the U.S. In the recent past, Pennsylvania-based Heritage Valley Health System, California-based non-profit healthcare provider PIH Health, as well as Australia’s Appalachian Regional Healthcare System have implemented the Sunrise solutions in their hospitals.

MDRX posted a significant fall in adjusted earnings to $1.4 million or a penny per share in the third quarter of 2013 from $31.9 million or 19 cents in the comparable quarter of 2012. With this, earnings also missed the Zacks Consensus Estimate of 4 cents for the quarter.

Revenues in the quarter ebbed 8.5% to $330.2 million, while after considering deferred revenues and other adjustments, revenues stood at $334.2 million, up 7.4% from the prior-year quarter. With this, revenues also missed the Zacks Consensus Estimate of $355 million. The decrease can be attributable to lower revenues generated from all the operating segments.

Currently, Allscripts Healthcare retains a Zacks Rank #3 (Hold). Since we consider no other stocks from the medical information systems as favorable at this moment, we can take a look at some medical products stock that are doing well. They include NuVasive, Inc. (NUVA - Snapshot Report), Hill-Rom Holdings, Inc. (HRC - Snapshot Report) and INSYS Therapeutics, Inc. (INSY - Snapshot Report). All of them carry a Zacks Rank #1 (Strong Buy).

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
SUPER MICRO… SMCI 27.00 +10.25%
CANADIAN SO… CSIQ 38.34 +8.18%
CENTURY ALU… CENX 26.97 +7.97%
WILLDAN GRO… WLDN 11.38 +5.86%
AROTECH COR… ARTX 3.78 +5.59%